|
|
|
|
|
|
|
|
|
|
Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin
World J Clin Oncol. 2012 October 10; 3(10): 137–141.
Published online 2012 October 10. doi: 10.5306/wjco.v3.i10.137
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.